The possible role of antioxidant vitamin C in Alzheimer's disease treatment and prevention

American Journal of Alzheimer's Disease and other Dementias

Volumn 28, Issue 2, 2013, Pages 120-125

  Heo, Jae Hyeok ^a   Hyon Lee, ^b   Lee, Kyoung Min ^b  

^a Seoul Medical Center   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Alzheimer's disease; oxidative stress; vitamin C

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; NITRIC OXIDE; SODIUM ASCORBIC ACID COTRANSPORTER; SODIUM ASCORBIC ACID COTRANSPORTER 2; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BLOOD BRAIN BARRIER; BRAIN METABOLISM; CEREBROSPINAL FLUID LEVEL; DIET SUPPLEMENTATION; ENDOTHELIAL DYSFUNCTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; REVIEW; RISK REDUCTION; VITAMIN METABOLISM;

EID: 84876541043     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317512473193     Document Type: Review

References (67)

1. Ferri CP, Prince M, Brayne C, et al. Alzheimer's disease international: global prevalence of dementia: a delphi consensus study. Lancet. 2005 ; 366 (9503). 2112-2117
2. Yao Y, Chinnici C, Tang H, Trojanowski JQ, Lee VM, Pratico D.. Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis. J Neuroinflammation. 2004 ; (1) (1). 21
3. Choudhry F, Howlett DR, Richardson JC, Francis PT, Williams RJ. Pro-oxidant diet enhances beta/gamma secretase-mediated APP processing in APP/PS1 transgenic mice. Neurobiol Aging. 2012 ; 33 (5). 960-968
4. Murakami K, Shimizu T. Cytoplasmic superoxide radical: a possible contributing factor to intracellular Aβ oligomerization in Alzheimer disease. Commun Integr Biol. 2012 ; 5 (3). 255-258
5. Bowman GL. Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction. Biofactors. 2012 ; 38 (2). 114-122
6. Feng Y, Wang X.. Antioxidant therapies for Alzheimer's disease. Oxid Med Cell Longev. 2012 ;:
7. Murakami K, Murata N, Ozawa Y, et al. Vitamic C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease. J Alzheimers Dis. 2011 ; 26 (1). 7-18
8. Padayatty SJ, Katz A, Wang Y, et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003 ; 22 (1). 18-35
9. Nualart FJ, Rivas CI, Montecinos VP, et al. Recycling of vitamin C by a bystander effect. J Biol Chem. 2003 ; 278 (12). 10128-10133
10. Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000 ; 23 (5). 209-216
11. Lewin S Vitamin C: Its Molecular Biology and Medical Potential. London, England: Academic Press ; 1976:
12. Angelow S, Haselbach M, Galla HJ. Functional characterisation of the active ascorbic acid transport into cerebrospinal fluid using primary cultured choroid plexus cells. Brain Res. 2003 ; 988 (1-2). 105-113
13. Spector R. Vitamin homeostasis in the central nervous system. N Engl J Med. 1977 ; 296 (24). 1393-1398
14. Farrell CL, Yang J, Pardridge WM. GLUT-1 glucose transporter is present within apical and basolateral membranes of brain epithelial interfaces and in microvascular endothelia with and without tight junctions. J Histochem Cytochem. 1992 ; 40 (2). 193-199
15. Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med. 2009 ; 46 (6). 719-730
16. Mun GH, Kim MJ, Lee JH, et al. Immunohistochemical study of the distribution of sodium-dependent vitamin C transporters in adult rat brain. J Neurosci Res. 2006 ; 83 (5). 919-928
17. Castro M, Caprile T, Astuya A, et al. High-affinity sodium-vitamin C co-transporters (SVCT) expression in embryonic mouse neurons. J Neurochem. 2001 ; 78 (4). 815-823
18. Christen Y.. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000 ; 71: 621-9
19. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol. 1994 ; 36 (5). 747-751
20. Marcus DL, Thomas C, Rodriguez C, et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol. 1998 ; 150 (1). 40-44
21. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci. 1997 ; 17 (8). 2653-2657
22. Pappolla MA, Omar RA, Kim KS, Robakis NK. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am J Pathol. 1992 ; 140 (3). 621-628
23. Schipper HM, Cisse S, Stopa EG.. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol. 1995 ; 37 (()). 758-768
24. Naseer MI, Ullah I, Ullah N, et al. Neuroprotective effect of vitamin C against PTZ induced apoptotic neurodegeneration in adult rat brain. Pak J Pharm Sci. 2011 ; 24 (3). 263-268
25. Riviere S, Birlouez-Aragon I, Nourhashemi F, Vellas B. Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry. 1998 ; 13 (11). 749-754
26. Quinn J, Suh J, Moore MM, Kaye J, Frei B. Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain. J Alz Dis. 2003 ; 5 (4). 309-313
27. Reiber H, Ruff M, Uhr M.. Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate. Clin Chim Acta. 1993 ; 217 (2). 163-173
28. Harrison FE, Hosseini AH, McDonald MP, May JM. Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice. Pharmacol Biochem Behav. 2009 ; 93 (4). 443-450
29. Rosales-Corral S, Tan DX, Reiter RJ, et al. Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-beta peptide in rat brain: a comparative, in vivo study versus vitamin C and E. J Pineal Res. 2003 ; 35 (2). 80-84
30. Huang J, May JM. Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid. Brain Res. 2006 ; 1097 (1). 52-58
31. Abe T, Tohgi H, Isobe C, Murata T, Sato C. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002 ; 70 (3). 447-450
32. Dhingra D, Parle M, Kulkarni SK. Comparative brain cholinesterase- inhibitng activity of Glycyrrhiza glabra, Myristica fragrans, ascorbic acid, and metrifonate in mice. J Med Food. 2006 ; 9 (2). 281-283
33. Kuo CH, Hata F, Yoshida H, Yamatodani A, Wada H. Effect of ascorbic acid on release of acetylcholine from synaptic vesicles prepared from different species of animals and release of noradrenaline from synaptic vesicles of rat brain. Life Sci. 1979 ; 24 (10). 911-915
34. Cheng F, Cappai R, Ciccotosto GD, et al. Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparin sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation. J Biol Chem. 2011 ; 286 (31). 27559-27572
35. Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology. 2000 ; 54 (6). 1265-1272
36. Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002 ; 287 (24). 3230-3237
37. Luchsinger JA, Tang MX, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol. 2003 ; 60 (2). 203-208
38. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2001 ; 287 (24). 3223-3229
39. Zandi PP, Anthony JC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in uvsers of antioxidant vitamin supplements: the Cache County Study. Arch Neurol. 2004 ; 61 (1). 82-88
40. Laditka JN, Laditka SB, Tait EM, Tsulukidze MM. Use of dietary supplements for cognitive health: results of a national survey of adults in the United States. Am J Alzheimers Dis Other Demen. 2012 ; 27 (1). 55-64
41. Snowden M, Steinman L, Mochan K, et al. Effect of exercise on cognitive performance in community dwelling older adults: review of intervention trials and recommendations for public health practice and research. J Am Geriatr Soc. 2011 ; 59 (4). 704-16
42. Bomboi G, Castello L, Cosentino F, Giubilei F, Orzi F, Volpe M. Alzheimer's disease and endothelial dysfunction. Neurol Sci. 2010 ; 31 (1). 1-8
43. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun study. JAMA. 1997 ; 277 (10). 813-817
44. Pasquier F, Henon H, Leys D.. Relevance of white matter changes to pre- and poststroke dementia. Ann N Y Acad Sci. 2000 ; 903: 466-469
45. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003 ; 348 (13). 1215-1222
46. Qiu C, Winblad B, Viitanen M, Fratigliioni L. Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community based, longitudinal study. Stroke. 2003 ; 34 (3). 594-549
47. Wallace SM, Yasmin McEniery CM, et al. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension. 2007 ; 50 (1). 228-233
48. Scuteri A, Tesauro M, Appolloni S, Preziosi F, Brancati AM, Volpe M. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens. 2007 ; 25: 1035-1040
49. Bell RD, Zlokovic BV. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009 ; 118 (1). 103-113
50. Dede DS, Yavuz B, Yavuz BB, et al. Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease?. Geriatr Soc. 2007 ; 55 (10). 1613-1617
51. Shibata M, Yamada S, Kumar SR, et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000 ; 106 (12). 1489-1499
52. Deane R, Bell RD, Sagare A, Zlokovic BV. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets. 2009 ; 8 (1). 16-30
53. Miller MC, Tavares R, Johanson CE, et al. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Res. 2008 ; 1230: 273-280
54. Donahue JE, Flaherty SL, Johanson CE, et al. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol. 2006 ; 112 (4). 405-415
55. Lin JL, Huang YH, Shen YC, Huang HC, Liu PH. Ascorbic acid prevents blood-brain barrier disruption and sensory deficit caused by sustained compression of primary somatosensory cortex. J Cereb Blood Flow Metab. 2010 ; 30 (6). 1121-1136
56. May JM, Qu ZC. Nitric oxide mediates tightening of the endothelial barrier by ascorbic acid. Biochem Biophys Res Commun. 2011 ; 404 (2). 701-705
57. Tsao PS, Aoki N, Lefer DJ, Johnson III G, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 1990 ; 82 (4). 1402-1412
58. Wever R, Stroes E, Rabelink TJ. Nitric oxide and hypercholesterolemia: a matter of oxidation and reduction?. Atherosclerosis. 1998 ; 137 (suppl). S51 - S60
59. May JM. How does ascorbic acid prevent endothelial dysfunction. Free Radic Biol Med. 2000 ; 28 (9). 1421-1429
60. Kaneko T, Kaji K, Matsuo M. Protective effect of lipophilic derivatives of ascorbic acid on lipid peroxide-induced endothelial injury. Arch Biochem Biophys. 1993 ; 304 (1). 176-180
61. May JM, Qu ZC. Ascorbic acid prevents increased endothelial permeability caused by oxidized low density lipoprotein. Free Radic Res. 2010 ; 44 (11). 1359-1368
62. Scorza G, Pietraforte D, Minetti M. Role of ascorbate and protein thiols in the release of nitric oxide from S-nitroso-albumin and S-nitroso-gluthathione in human plasma. Free Radic Biol Med. 1997 ; 22 (4). 633-642
63. Millar J. The nitric oxide/ascorbate cycle: how neurons may control their own oxygen supply. Med Hypotheses. 1995 ; 45 (1). 21-26
64. Ischiropoulos H. Biological tyrosine nitrationa pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998 ; 356 (1). 1-11
65. Bendich A, Machlin LJ, Scandurra O, Burton GW, Wayner DM.. The antioxidant role of vitamin C. Adv Free Radic Biol Med. 1986 ; 2: 419-444
66. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, Werner ER. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem. 2001 ; 276 (1). 40-47
67. Pleiner J, Schaller G, Mittermayer F, et al. Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion. Atherosclerosis. 2008 ; 197 (1). 383-391